Protocol
Tissue Repair
BPC-157 + GHK-Cu Recovery and Skin Stack [2026]
Internal tissue repair via BPC-157 combined with GHK-Cu for skin, collagen, and surface wound healing in a single protocol.
Compounds
BPC-157
Dose: 500 mcg
Freq: Once daily
Recon: 5mg + 2mL BAC
Conc: 2,500 mcg/mL
Draw: 20 units (U-100)
Calculate BPC-157 dose
GHK-Cu
Dose: 1 mg
Freq: Once daily
Recon: 50mg + 10mL BAC
Conc: 5 mg/mL
Draw: 20 units (U-100)
Calculate GHK-Cu dose
Protocol Phases
Full Stack
Weeks 1 to 12
BPC-157 500 mcg SubQ in morning near injury site. GHK-Cu 1 mg SubQ in evening. Inject each separately. Optional topical GHK-Cu serum applied to skin target areas 1 to 2 times daily.
FAQ
Do BPC-157 and GHK-Cu have complementary mechanisms?
Yes. BPC-157 drives tissue repair through nitric oxide signaling, growth factor upregulation, and tendon fibroblast stimulation. GHK-Cu promotes collagen and glycosaminoglycan synthesis and reduces inflammation through a separate pathway involving SPARC and TGF-beta1. Together they address repair from multiple angles.
Can BPC-157 and GHK-Cu be injected together?
They can technically be drawn into the same syringe but research protocols typically administer them at different times of day to track individual responses and reduce volume at any single injection site.
Is topical GHK-Cu effective alongside SubQ dosing?
Yes. Topical GHK-Cu serums (typically 1 to 2% concentration) penetrate the dermis and produce local collagen stimulation. Combined with systemic SubQ dosing, both routes address different tissue depths and are often used together in skin aging and wound healing research.
Research Notes
- Inject BPC-157 and GHK-Cu at separate sites and times.
- GHK-Cu solution has a distinct blue-green color due to copper chelation. This is normal and expected.
- This stack is suitable for concurrent gut health and skin repair research given BPC-157 oral bioavailability option.
Related Protocols
For research use only. Not medical advice.